+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Postbiotics Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 181 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924776
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global postbiotics market is redefining health innovation, with executive teams pivoting towards scientifically substantiated, shelf-stable solutions that meet strict regulatory needs. As scrutiny intensifies on clinical support and robust supply chains, organizations are refocusing strategies to maintain operational reliability, regulatory alignment, and long-term advantage.

Market Snapshot: Postbiotics Market Size & Growth

The postbiotics market is experiencing accelerated growth, propelled by rising demand for stable, evidence-backed bioactive ingredients and a shift away from live cultures. Stricter regulatory environments and the proliferation of analytical tools are enabling manufacturers to build standardized, high-quality offerings. Innovation is expanding beyond nutrition to influence retail, specialty health, and wellness categories, where companies increasingly rely on credible claims and transparent ingredient sourcing to distinguish their portfolios from competitors.

Scope & Segmentation of the Postbiotics Market

This analysis offers senior leaders a comprehensive view of key segments that drive informed decisions and commercial progress:

  • Product Type: Bacterial lysates, exopolysaccharides, functional proteins, lipoteichoic acids, peptidoglycan fragments, bacteriocins, organic acids, short-chain fatty acids, tryptophan or indole derivatives, and vitamins. Each supports targeted clinical and functional applications.
  • Form: Dry forms such as capsules, powders, tablets as well as liquids and semi-solids (gels, gummies), tailored for different stability needs and user preferences.
  • Source: Derived from bacterial or yeast strains, catering to both therapeutic and daily functional usage.
  • Formulation: Encapsulated and unencapsulated choices empower brands to control release profiles, product integrity, and dosage accuracy.
  • Processing Method: Chemical treatment, enzymatic hydrolysis, freeze-drying, heat treatments, high-pressure processing, irradiation, microencapsulation, and ultrasonication all reinforce consistency and safety.
  • Packaging Type: Includes bottles, sachets, and stick packs, aligned with logistics efficiency and product preservation.
  • Application: Covers animal nutrition (aquaculture, livestock, pets), cosmetics, personal care, food and beverages (dairy, functional food, infant nutrition), human health, and pharmaceuticals to support wide-ranging value propositions.
  • End User: Reaches companion animals, adults, geriatric and pediatric populations, and livestock categories such as poultry and swine.
  • Distribution Channel: Spans offline (pharmacies, specialty retailers, supermarkets) and online platforms, connecting direct manufacturers to e-commerce sites for wider market access.
  • Geographic Coverage: Opportunities in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with each region influenced by shifting regulations and evolving market entry tactics.
  • Key Companies: Leading players include Archer Daniels Midland Company, BASF SE, Kerry Group plc, Kirin Holdings, Lallemand Inc, Novonesis Group, Mitsubishi Corporation, and other innovators driving technological advancement and shaping the competitive field.
  • Technology Use: Advanced analytical tools, omics, metabolomics, sophisticated encapsulation, batch traceability, and stringent documentation deliver product quality and regulatory assurance.

Key Takeaways: Strategic Insights for Executive Decision-Makers

  • Continuous enhancements in formulation and process methods are ensuring extended shelf-life and reliability in postbiotic delivery for regional and global supply chains.
  • Cross-functional alignment among R&D, compliance, and commercial teams is translating scientific results into market-ready innovations with defensible value propositions.
  • Evidence-based claims are increasingly central to product positioning, building trust across a broad spectrum of consumer demographics and professional buyers.
  • Engagement with regulatory authorities is vital for clarifying permissible health statements, completing required documentation, and streamlining market approvals in multiple regions.
  • Agile supply chain management—with adaptive sourcing and procurement—mitigates volatility associated with trade disruptions and new policy measures.
  • Adopting flexible quality standards tailored to unique local requirements supports scalable, sustainable growth even in complex regulatory climates.

Tariff Impact on the Postbiotics Market

Unpredictable tariff changes, especially in U.S. markets, prompt companies to revisit supply chain structures and widen sourcing strategies. Measures such as moving production, adjusting packaging, and utilizing trade agreements are applied to control costs and maintain reliable product flows. Involving customs specialists and refining logistics partnerships further reduce fiscal and operational risk, underpinning supply continuity.

Postbiotics Market Methodology & Data Sources

This report is grounded in direct interviews with experts spanning scientific, regulatory, and logistical fields, supplemented by synthesis of peer-reviewed clinical literature. This robust methodological approach ensures relevance and actionability for strategic decision-makers.

Why This Report Matters for Senior Leaders

  • Identifies the most dynamic postbiotic technologies and segments, equipping executives to steer clear of commoditization and enhance competitive value.
  • Prepares organizations to anticipate and respond swiftly to complex, evolving global and regional regulatory shifts for consistent compliance.
  • Enables scenario-based, risk-informed planning to address procurement, logistics, and tariff uncertainties with confidence and agility.

Conclusion

Postbiotics create a viable path to operational strength and scientific credibility. Senior leaders who embrace agile innovation and compliance are well-positioned to navigate the sector’s rapid evolution and capture emerging value opportunities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rising incorporation of postbiotics in functional foods and beverages
5.2. Emerging consumer preference for natural and sustainable postbiotic products
5.3. Synergistic effects of postbiotics combined with prebiotics and probiotics in supplements
5.4. Development of targeted postbiotic therapies for chronic inflammatory diseases
5.5. Collaborations between biotech firms and food companies accelerating postbiotic innovation
5.6. Influence of regulatory frameworks on postbiotic product development
5.7. Expansion of postbiotic applications in skincare and dermatology sectors
5.8. Increased research highlighting postbiotics' role in immune system support
5.9. Growth in personalized nutrition driving demand for postbiotic supplements
5.10. Advancements in postbiotic formulations enhancing gut health benefits
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Postbiotics Market, by Product Type
8.1. Cell Components
8.1.1. Bacterial Lysates
8.1.2. Exopolysaccharides
8.1.3. Functional Proteins
8.1.4. Lipoteichoic Acids
8.1.5. Peptidoglycan Fragments
8.2. Enzymes
8.3. Metabolites
8.3.1. Bacteriocins
8.3.2. Organic Acids
8.3.3. Short-Chain Fatty Acids
8.3.3.1. Acetate
8.3.3.2. Butyrate
8.3.3.3. Propionate
8.3.4. Tryptophan/Indole Derivatives
8.3.5. Vitamins
9. Postbiotics Market, by Form
9.1. Dry
9.1.1. Capsules
9.1.2. Powder
9.1.3. Tablets
9.2. Liquid
9.2.1. Solutions
9.2.2. Suspensions
9.3. Semi-Solid
9.3.1. Gels
9.3.2. Gummies
10. Postbiotics Market, by Source
10.1. Bacterial Derived
10.2. Yeast Derived
11. Postbiotics Market, by Formulation
11.1. Encapsulated
11.2. Unencapsulated
12. Postbiotics Market, by Processing Method
12.1. Chemical Treatment
12.2. Enzymatic Hydrolysis
12.3. Freeze Drying
12.4. Heat Treatment
12.4.1. Pasteurization
12.4.2. Sterilization
12.4.3. Tyndallization
12.5. High-Pressure Processing
12.6. Irradiation
12.7. Microencapsulation
12.7.1. Coacervation
12.7.2. Fluid Bed Coating
12.7.3. Liposomal Encapsulation
12.7.4. Spray-Dry Encapsulation
12.8. Spray Drying
12.9. Ultrasonication
13. Postbiotics Market, by Packaging Type
13.1. Bottles
13.2. Sachets
13.3. Stick Packs
14. Postbiotics Market, by Application
14.1. Animal Nutrition
14.1.1. Aquaculture Feed
14.1.2. Livestock Feed
14.1.3. Pet Food & Treats
14.2. Cosmetics & Personal Care
14.2.1. Hair Care
14.2.2. Oral Care
14.2.3. Skin Care
14.3. Food & Beverages
14.3.1. Beverages
14.3.2. Dairy & Dairy Alternatives
14.3.3. Functional Food
14.3.4. Infant Formula
14.4. Human Nutrition
14.4.1. Dietary Supplements
14.4.2. Functional Foods & Beverages
14.5. Pharmaceuticals
15. Postbiotics Market, by End User
15.1. Companion Animals
15.1.1. Cats
15.1.2. Dogs
15.2. Human
15.2.1. Adults
15.2.2. Geriatrics
15.2.3. Pediatrics
15.3. Livestock
15.3.1. Poultry
15.3.2. Ruminants
15.3.3. Swine
16. Postbiotics Market, by Distribution Channel
16.1. Offline Retail
16.1.1. Pharmacies & Drug Stores
16.1.2. Specialty Store
16.1.3. Supermarkets & Hypermarkets
16.2. Online Retail
16.2.1. eCommerce Websites
16.2.2. Manufacturer Websites
17. Postbiotics Market, by Region
17.1. Americas
17.1.1. North America
17.1.2. Latin America
17.2. Europe, Middle East & Africa
17.2.1. Europe
17.2.2. Middle East
17.2.3. Africa
17.3. Asia-Pacific
18. Postbiotics Market, by Group
18.1. ASEAN
18.2. GCC
18.3. European Union
18.4. BRICS
18.5. G7
18.6. NATO
19. Postbiotics Market, by Country
19.1. United States
19.2. Canada
19.3. Mexico
19.4. Brazil
19.5. United Kingdom
19.6. Germany
19.7. France
19.8. Russia
19.9. Italy
19.10. Spain
19.11. China
19.12. India
19.13. Japan
19.14. Australia
19.15. South Korea
20. Competitive Landscape
20.1. Market Share Analysis, 2024
20.2. FPNV Positioning Matrix, 2024
20.3. Competitive Analysis
20.3.1. Archer Daniels Midland Company
20.3.2. BASF SE
20.3.3. Cargill Incorporated
20.3.4. DSM-Firmenich AG
20.3.5. Kerry Group plc
20.3.6. Kirin Holdings Company, Limited.
20.3.7. Mitsubishi Corporation
20.3.8. MRM Nutrition
20.3.9. Lesaffre group
20.3.10. ABbiotek Health
20.3.11. Novonesis Group
20.3.12. International Flavors & Fragrances Inc.

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Postbiotics market report include:
  • Archer Daniels Midland Company
  • BASF SE
  • Beekeeper's Naturals, Inc.
  • Bioflag Co., Ltd. by AUSNUTRIA DAIRY CORPORATION LTD
  • Cargill Incorporated
  • Dr Emil Nutrition
  • DSM-Firmenich AG
  • Essential Formulas Incorporated
  • GeneFerm Biotechnology Co., Ltd.
  • Glac Biotech Co., Ltd.
  • GutArmor by Get Wellness, LLC
  • Healist Naturals, LLC
  • ILDONG BIOSCIENCE CO.,LTD.
  • Kemin Industries, Inc.
  • Kerry Group plc
  • Kirin Holdings Company, Limited.
  • Maypro Group
  • Mitsubishi Corporation
  • MRM Nutrition
  • Lesaffre group
  • ​POSTBIOTICA S.R.L.
  • Probioway Co., Ltd.
  • Postbiotics Inc.
  • Sabinsa Corporation
  • Silab SA
  • woresan GmbH
  • ABbiotek Health
  • Novonesis Group
  • International Flavors & Fragrances Inc.
  • MORINAGA MILK INDUSTRY CO.,LTD.
  • Lallemand Inc